Lucas Gregory M, Solomon Sunil S, Srikrishnan Aylur K, Agrawal Alok, Iqbal Syed, Laeyendecker Oliver, McFall Allison M, Kumar Muniratnam S, Ogburn Elizabeth L, Celentano David D, Solomon Suniti, Mehta Shruti H
aJohns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland, USA bY.R. Gaitonde Centre for AIDS Research and Education, Chennai, Tamil Nadu cAll India Institute of Medical Sciences, Department of Psychiatry, New Delhi, India dLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health eJohns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
AIDS. 2015 Mar 13;29(5):619-28. doi: 10.1097/QAD.0000000000000592.
Injecting drug use has historically been the principal driver of the HIV epidemic in the northeast states of India. However, recent data indicate growing numbers of people who inject drugs (PWIDs) in north and central Indian cities.
We conducted face-to-face surveys among PWIDs in seven northeast and eight north/central Indian cities using respondent-driven sampling. We used a rapid HIV-testing protocol to identify seropositive individuals and multiassay algorithm to identify those with recent infection. We used multilevel regression models that incorporated sampling weights and had random intercepts for site to assess risk factors for prevalent and incident (recent) HIV infection.
We surveyed 14 481 PWIDs from 15 Indian cities between January and December 2013. Participants reported high rates of needle/syringe sharing. The median (site range) estimated HIV prevalence and incidence were 18.1% (5.9, 44.9) and 2.9 per 100 person-years (0, 12.4), respectively. HIV prevalence was higher in northeast sites, whereas HIV incidence was higher in north/central sites. The odds of prevalent HIV were over three-fold higher in women than in men. Other factors associated with HIV prevalence or incidence included duration since first injection, injection of pharmaceutical drugs, and needle/syringe sharing.
The burden of HIV infection is high among PWIDs in India, and may be increasing in cities where injecting drug use is emerging. Women who inject drugs were at substantially higher risk for HIV than men - a situation that may be mediated by dual injection-related and sexual risks.
在印度东北部各邦,注射吸毒历来是艾滋病流行的主要驱动因素。然而,近期数据显示,印度北部和中部城市注射吸毒者(PWID)的数量在不断增加。
我们采用应答者驱动抽样方法,对印度东北部7个城市和北部/中部8个城市的注射吸毒者进行了面对面调查。我们使用快速艾滋病毒检测方案来识别血清反应阳性个体,并使用多检测算法来识别近期感染的个体。我们使用了纳入抽样权重并对地点设置随机截距的多级回归模型,以评估艾滋病流行感染和新发(近期)感染的风险因素。
2013年1月至12月期间,我们对来自印度15个城市的14481名注射吸毒者进行了调查。参与者报告的针头/注射器共用率很高。估计的艾滋病病毒流行率和发病率中位数分别为18.1%(5.9,44.9)和每100人年2.9例(0,12.4)。东北部地区的艾滋病病毒流行率较高,而北部/中部地区的艾滋病病毒发病率较高。女性艾滋病病毒流行率的几率是男性的三倍多。与艾滋病病毒流行率或发病率相关的其他因素包括首次注射后的持续时间、注射药品以及针头/注射器共用。
印度注射吸毒者中的艾滋病毒感染负担很高,在注射吸毒现象正在出现的城市中可能还在增加。注射吸毒的女性感染艾滋病毒的风险比男性高得多——这种情况可能是由与注射相关和性方面的双重风险介导的。